Rick Zall is chair of Proskauer's Health Care Group. Rick advises health care companies, investors and lenders in their most challenging transactions, including mergers and acquisitions, joint ventures, financings and complex commercial agreements.
With a deep understanding of the health care industry, Rick is known for providing practical, creative solutions in order to successfully close deals for his clients.
Rick advises clients on state and federal health care regulatory compliance matters, including the corporate practice of medicine, digital health, telemedicine, HIPAA, fraud and abuse, Medicare and Medicaid payment reimbursement, MACRA, and value based payment.
Rick advises clients on state and federal health care regulatory compliance matters, including the corporate practice of medicine, digital health, telemedicine, HIPAA, fraud and abuse, Medicare and Medicaid payment reimbursement, and value based payment. As businesses globally are impacted by the Coronavirus (COVID-19) pandemic, Rick is a member of the firm’s Coronavirus Response Team helping clients respond and solve issues across myriad fronts, from understanding CARES Act programs to compliance with applicable state and local guidelines for employers to follow.
Rick is a respected thought leader in the health care industry and frequently presents at key industry events. He has served in government, is a co-founder of the New York Primary Care Development Corporation (PCDC), and earlier in his career was CEO of a private equity-backed medical management company. Rick has also directed two industry studies for the Robert Wood Johnson Foundation and serves as principal outside counsel and board secretary to the Clinton Health Access Initiative (CHAI).